IONCTURA

HQ - Geneva

Summary

iOnctura is a clinical-stage biopharmaceutical company combating neglected and hard-to-treat cancers with precision oral small molecules that target cancers in novel ways.

Deals Overview

Total Deals1

Valued Deals1

Total Value£ 68 M

Avg. Deal Size£ 68 M

Market Context

Senior Management

Catherine Pickering
CEO